[Wild-type gastroinestinal stromal tumors].

[Wild-type gastroinestinal stromal tumors].
Bull Cancer. 2020 Feb 13;:
Authors: Djerouni M, Dumont SN
Abstract
Gastrointestinal stromal tumors (GIST) are the most common non-epithelial tumors of the gastrointestinal tract. Wild-type GISTs (WT-GIST) consist of a rare heterogeneous group characterized by the lack of activating mutations in the tyrosine kinase receptor (Kit) and/or platelet derived growth factor receptor A (PDGFRA). However, WT-GIST is characterized by other genomic alterations, including dehydrogenase succinate (SDH) deficiency or mutations in the Ras pathway. Recent studies have reported many mutations in others genes that may be incriminated in the development of WT-GISTs. Moreover, WT-GIST is frequently associated with hereditary cancer syndromes such as the Carney Triad and Type 1 Neurofibromatosis (NF1). WT-GIST affects usually young and pediatric patients. Most WT-GIST subtypes are insensitive to imatinib; therefore, their therapeutic management is somewhat different from usual GISTs. This review resumes the molecular and therapeutic features of this rare entity.
PMID: 32063345 [PubMed - as supplied by publisher]

Source: Bulletin du Cancer - February 12, 2020 Category: Cancer & Oncology Authors: Djerouni M, Dumont SN Tags: Bull Cancer Source Type: research